Association Between Beta-Blocker or Statin Drug Use and the Risk of Hemorrhage From Cerebral Cavernous Malformations.
Susanna M ZuurbierCharlotte R HickmanLeon A RinkelRebecca BergUlrich SureRustam Al-Shahi Salmannull nullPublished in: Stroke (2022)
Beta-blocker, but not statin, use was associated with a lower risk of intracranial hemorrhage or persistent/progressive focal neurological deficit in patients with CCM.